Mosaic
MOS NYSE Fertilizers & Agricultural Chemicals Financials FY2016βFY2025
Mosaic's revenue rose 8.4% to $12.1 billion in fiscal 2025. Its operating margin was 6.8%, up from 5.6% a year earlier. Free cash flow was β$535 million, against $47 million a year earlier. It paid out $280 million in dividends and buybacks. The diluted share count fell 0.6%.
What Mosaic does
No business description yet.
- Legal name
- MOSAIC CO
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001285785-26-000017
0001285785
Revenue and margins
Mosaic had $12.1B of revenue in fiscal 2025, up 8.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$535M in fiscal 2025, β4.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Mosaic returned $280M to shareholders in fiscal 2025. The diluted share count fell 0.6%.
Value Mosaic yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.8B and divides by 318.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Balance sheet
Cash, debt and the ratios that show how comfortably Mosaic can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $770M | $735M | $349M | $273M | $277M |
| Debt incl. finance leases | $4.3B | $3.6B | $3.8B | $4.2B | $5.1B |
| Net debt / EBITDA | 1.1x | 0.5x | 1.5x | 2.4x | 2.6x |
| Debt / equity | 0.4x | 0.3x | 0.3x | 0.4x | 0.4x |
| Interest coverage | 12.7x | 28.4x | 7.1x | 2.7x | 3.4x |
| Current ratio | 1.1x | 1.2x | 1.2x | 1.1x | 1.3x |
| Quick ratio | 0.5x | 0.5x | 0.6x | 0.5x | 0.5x |
| Total assets | $22.0B | $23.4B | $23.0B | $22.9B | $24.5B |
| Total liabilities | $11.3B | $11.2B | $10.6B | $11.3B | $12.2B |
| Shareholders' equity | $10.6B | $12.1B | $12.3B | $11.5B | $12.1B |
| Net debt (β = net cash) | $3.5B | $2.9B | $3.4B | $4.0B | $4.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
1 insider
Sold, 12 months
$0.5M
1 insider
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 4 / 9 | 8 / 9 |
| Accruals ratio | β5.4% | β4.9% | β1.2% |
| Altman Z'' | 3.89 | 3.33 | 3.50 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Mosaic MOS | $5.7B | 8.4% | 6.8% | β4.4% | 2.5% | β | 8 | |
| Corteva CTVA | $8.3B | 2.9% | β | 16.2% | 5.8% | 8.2x | 8 | Compare β |
| CF Industries CF | $18.6B | 19.3% | 32.5% | 25.4% | 20.6% | 9.0x | 8 | Compare β |
| FMC FMC | $633M | β18.3% | β47.0% | β3.0% | β19.6% | β | 2 | Compare β |
| Scotts Miracle-Gro SMG | $3.5B | β3.9% | 10.5% | 8.0% | 13.4% | 50.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.2B | $7.4B | $9.6B | $8.9B | $8.7B | $12.4B | $19.1B | $13.7B | $11.1B | $12.1B |
| Gross profit | $810M | $843M | $1.5B | $897M | $1.1B | $3.2B | $5.8B | $2.2B | $1.5B | $1.9B |
| Operating income | $319M | $466M | $928M | β$1.1B | $413M | $2.5B | $4.8B | $1.3B | $622M | $822M |
| Interest expense | $141M | $171M | $216M | $216M | $214M | $194M | $169M | $189M | $230M | $242M |
| Pretax income | $242M | $374M | $552M | β$1.3B | $181M | $2.2B | $4.6B | $1.3B | $315M | $1.2B |
| Income tax | β$74.2M | $495M | $77.1M | β$225M | β$579M | $598M | $1.2B | $177M | $187M | $640M |
| Net income | $298M | β$107M | $470M | β$1.1B | $666M | $1.6B | $3.6B | $1.2B | $175M | $541M |
| Diluted EPS | $0.85 | β$0.31 | $1.22 | β$2.78 | $1.75 | $4.27 | $10.06 | $3.50 | $0.55 | $1.70 |
| Diluted shares | 0.35B | 0.35B | 0.39B | 0.38B | 0.38B | 0.38B | 0.36B | 0.33B | 0.32B | 0.32B |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $936M | $1.4B | $1.1B | $1.6B | $2.2B | $3.9B | $2.4B | $1.3B | $825M |
| Capital expenditure | $843M | $820M | $955M | $1.3B | $1.2B | $1.3B | $1.2B | $1.4B | $1.3B | $1.4B |
| Free cash flow | $417M | $115M | $455M | β$177M | $412M | $898M | $2.7B | $1.0B | $47.4M | β$535M |
| Depreciation and amortization | $711M | $666M | $884M | $883M | $848M | $813M | $934M | $961M | $1.0B | $1.0B |
| Stock-based compensation | $30.5M | $28.0M | $27.5M | $27.9M | $17.8M | $29.5M | $27.9M | $33.0M | $31.8M | $30.7M |
| Acquisitions | $0.0M | $0.0M | $985M | $55.1M | $0.0M | $0.0M | $0.0M | $41.0M | $0.0M | $0.0M |
| Share buybacks | $75.0M | $0.0M | $0.0M | $150M | $0.0M | $411M | $1.7B | $756M | $235M | $0.0M |
| Dividends paid | $385M | $211M | $38.5M | $67.2M | $75.8M | $104M | $198M | $352M | $271M | $280M |
| Dividends and buybacks | $460M | $211M | $38.5M | $217M | $75.8M | $515M | $1.9B | $1.1B | $506M | $280M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $673M | $2.2B | $848M | $519M | $574M | $770M | $735M | $349M | $273M | $277M |
| Total debt | $3.8B | $5.2B | $4.5B | $4.6B | $4.6B | $4.3B | $3.6B | $3.8B | $4.2B | $5.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $345M | $345M | $213M | $194M | $180M | $145M | $176M |
| Current assets | $3.1B | $4.6B | $4.2B | $3.7B | $3.5B | $5.3B | $6.6B | $4.7B | $4.5B | $5.2B |
| Current liabilities | $1.5B | $2.0B | $2.5B | $2.6B | $3.1B | $4.8B | $5.5B | $3.9B | $4.2B | $4.0B |
| Inventory | $1.4B | $1.5B | $2.3B | $2.1B | $1.7B | $2.7B | $3.5B | $2.5B | $2.5B | $3.4B |
| Property and equipment, net | $9.2B | $9.7B | $11.7B | $11.7B | $11.9B | $12.5B | $12.7B | $13.6B | $13.4B | $14.0B |
| Total assets | $16.8B | $18.6B | $20.1B | $19.3B | $19.8B | $22.0B | $23.4B | $23.0B | $22.9B | $24.5B |
| Total liabilities | $7.2B | $9.0B | $9.5B | $9.9B | $10.0B | $11.3B | $11.2B | $10.6B | $11.3B | $12.2B |
| Shareholders' equity | $9.6B | $9.6B | $10.4B | $9.2B | $9.6B | $10.6B | $12.1B | $12.3B | $11.5B | $12.1B |
| Margins | ||||||||||
| Gross margin | 11.3% | 11.4% | 15.6% | 10.1% | 12.3% | 25.9% | 30.1% | 16.1% | 13.6% | 15.8% |
| Operating margin | 4.5% | 6.3% | 9.7% | β12.3% | 4.8% | 20.0% | 25.0% | 9.8% | 5.6% | 6.8% |
| EBITDA margin | 14.4% | 15.3% | 18.9% | β2.4% | 14.5% | 26.6% | 29.9% | 16.8% | 14.8% | 15.5% |
| Net margin | 4.2% | β1.5% | 4.9% | β12.0% | 7.7% | 13.2% | 18.7% | 8.5% | 1.6% | 4.5% |
| FCF margin | 5.8% | 1.6% | 4.8% | β2.0% | 4.8% | 7.3% | 14.1% | 7.3% | 0.4% | β4.4% |
| Returns | ||||||||||
| Return on capital | 2.6% | 1.8% | 5.9% | β6.2% | 3.0% | 12.9% | 24.0% | 7.5% | 2.0% | 2.5% |
| Return on capital employed | 2.1% | 2.9% | 5.4% | β6.4% | 2.5% | 14.6% | 27.3% | 7.2% | 3.3% | 4.2% |
| Return on equity | 3.1% | β1.1% | 4.7% | β10.9% | 7.1% | 16.2% | 31.6% | 9.6% | 1.5% | 4.6% |
| Return on assets | 1.7% | β0.6% | 2.4% | β5.4% | 3.4% | 7.8% | 15.8% | 5.0% | 0.8% | 2.3% |
| Growth | ||||||||||
| Revenue growth | β19.5% | 3.4% | 29.4% | β7.1% | β2.5% | 42.3% | 54.8% | β28.4% | β18.8% | 8.4% |
| Net income growth | β70.2% | β136.0% | β | β327.1% | β | 144.8% | 119.7% | β67.5% | β85.0% | 209.2% |
| EPS growth | β69.4% | β136.5% | β | β327.9% | β | 144.0% | 135.6% | β65.2% | β84.3% | 209.1% |
| FCF growth | β59.8% | β72.3% | 294.5% | β138.8% | β | 118.1% | 199.3% | β62.6% | β95.3% | β1,227.9% |
| Share count change | β2.4% | β0.2% | 10.1% | β0.7% | β0.7% | 0.1% | β6.7% | β6.4% | β3.8% | β0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.1x | 2.7x | 2.0x | β | 3.2x | 1.1x | 0.5x | 1.5x | 2.4x | 2.6x |
| Debt / equity | 0.4x | 0.5x | 0.4x | 0.5x | 0.5x | 0.4x | 0.3x | 0.3x | 0.4x | 0.4x |
| Interest coverage | 2.3x | 2.7x | 4.3x | β5.1x | 1.9x | 12.7x | 28.4x | 7.1x | 2.7x | 3.4x |
| Current ratio | 2.1x | 2.3x | 1.7x | 1.4x | 1.1x | 1.1x | 1.2x | 1.2x | 1.1x | 1.3x |
| Quick ratio | 1.1x | 1.5x | 0.8x | 0.6x | 0.6x | 0.5x | 0.5x | 0.6x | 0.5x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 11.8% | 11.1% | 10.0% | 14.3% | 13.5% | 10.4% | 6.5% | 10.2% | 11.3% | 11.3% |
| Stock comp / revenue | 0.4% | 0.4% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% |
| Payouts / FCF | 110.3% | 182.5% | 8.5% | β | 18.4% | 57.3% | 69.3% | 110.2% | 1,067.7% | β |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 6.0 | 7.0 | 3.0 | 7.0 | 7.0 | 9.0 | 5.0 | 4.0 | 8.0 |
| Altman Z'' | 4.3 | 4.1 | 3.8 | 2.7 | 3.0 | 3.7 | 4.8 | 3.9 | 3.3 | 3.5 |
| Accruals ratio | β5.6% | β5.9% | β4.9% | β11.0% | β4.7% | β2.7% | β1.6% | β5.4% | β4.9% | β1.2% |
Source: SEC EDGAR XBRL filings (CIK 0001285785). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.